Amphastar Pharmaceuticals Total Assets 2012-2024 | AMPH
Amphastar Pharmaceuticals total assets from 2012 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Amphastar Pharmaceuticals Annual Total Assets
(Millions of US $) |
| 2023 |
$1,513 |
| 2022 |
$742 |
| 2021 |
$672 |
| 2020 |
$631 |
| 2019 |
$587 |
| 2018 |
$514 |
| 2017 |
$451 |
| 2016 |
$428 |
| 2015 |
$390 |
| 2014 |
$389 |
| 2013 |
$339 |
| 2012 |
$317 |
| 2011 |
$0 |
| 2009 |
$300 |
Amphastar Pharmaceuticals Quarterly Total Assets
(Millions of US $) |
| 2024-09-30 |
$1,545 |
| 2024-06-30 |
$1,492 |
| 2024-03-31 |
$1,574 |
| 2023-12-31 |
$1,513 |
| 2023-09-30 |
$1,545 |
| 2023-06-30 |
$1,378 |
| 2023-03-31 |
$774 |
| 2022-12-31 |
$742 |
| 2022-09-30 |
$727 |
| 2022-06-30 |
$724 |
| 2022-03-31 |
$716 |
| 2021-12-31 |
$672 |
| 2021-09-30 |
$652 |
| 2021-06-30 |
$666 |
| 2021-03-31 |
$646 |
| 2020-12-31 |
$631 |
| 2020-09-30 |
$614 |
| 2020-06-30 |
$600 |
| 2020-03-31 |
$573 |
| 2019-12-31 |
$587 |
| 2019-09-30 |
$586 |
| 2019-06-30 |
$601 |
| 2019-03-31 |
$545 |
| 2018-12-31 |
$514 |
| 2018-09-30 |
$481 |
| 2018-06-30 |
$452 |
| 2018-03-31 |
$450 |
| 2017-12-31 |
$451 |
| 2017-09-30 |
$438 |
| 2017-06-30 |
$444 |
| 2017-03-31 |
$436 |
| 2016-12-31 |
$428 |
| 2016-09-30 |
$429 |
| 2016-06-30 |
$409 |
| 2016-03-31 |
$395 |
| 2015-12-31 |
$390 |
| 2015-09-30 |
$395 |
| 2015-06-30 |
$399 |
| 2015-03-31 |
$397 |
| 2014-12-31 |
$389 |
| 2014-09-30 |
$401 |
| 2014-06-30 |
$397 |
| 2014-03-31 |
$345 |
| 2013-12-31 |
$339 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$317 |
| 2012-09-30 |
$0 |
| 2012-06-30 |
$0 |
| 2012-03-31 |
$0 |
| 2011-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.840B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
